Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. Vidacs

The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia

Cancer Research

Cancer Research

English

Related publications

MN1 Is Indispensable for MLL-rearranged Acute Myeloid Leukemia

English

Inhibition of Flt3 and Pim Kinases by Ec-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia

Molecular Cancer Therapeutics

Cancer Research

English

Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia

Cancer Research

English

CDK9 Inhibitors in Acute Myeloid Leukemia

Journal of Experimental and Clinical Cancer Research

Cancer Research

English

Rationale for Targeting BCL6 in MLL-rearranged Acute Lymphoblastic Leukemia

Genes and Development

Developmental Biology

English

A Cyclin-Dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer

Multidisciplinary

English

TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models

Molecular Cancer Therapeutics

Cancer Research

English

Pin1 Inhibition Exerts Potent Activity Against Acute Myeloid Leukemia Through Blocking Multiple Cancer-Driving Pathways

Journal of Hematology and Oncology

Cancer Research

Molecular Biology

English

Multiple CDK Inhibitor Dinaciclib Suppresses Neuroblastoma Growth via Inhibiting CDK2 and CDK9 Activity

Scientific Reports

Multidisciplinary

English